Back to today’s briefing

Story perspectives

Trump's Tariff Threatens Access to Vital Medications

2/9/2025

33 3

Left

Trump's Tariff Threat

Experts caution that President Trump's 10 percent tariff on China could lead to soaring prices and shortages of vital generic medications in the U.S. With 30 percent of active pharmaceutical ingredients sourced from China, the American Hospital Association is calling for exemptions to safeguard patient care and ensure access to essential medical supplies.

Right

Trump Halts Tariffs

President Trump has temporarily halted tariffs on low-value packages from China, giving federal agencies a chance to adjust. This move comes after a recent 10% tariff hike on Chinese goods, sparking worries about potential delivery delays and rising costs. With over 1 billion packages crossing borders in 2023, the surge in e-commerce is reshaping the U.S. economy.

History

Historical Context

President Trump's tariffs on Chinese goods, particularly pharmaceuticals, echo past trade tensions, notably during the 1980s when Japan faced similar U.S. tariffs. The reliance on Chinese active pharmaceutical ingredients highlights vulnerabilities in the U.S. supply chain. Historical tariff impacts often led to price hikes and shortages, raising concerns about patient access to essential medications amid ongoing global trade disputes.

1 of 3

Trump's Tariff Threat

Experts caution that President Trump's 10 percent tariff on China could lead to soaring prices and shortages of vital generic medications in the U.S. With 30 percent of active pharmaceutical ingredients sourced from China, the American Hospital Association is calling for exemptions to safeguard patient care and ensure access to essential medical supplies.

1 / 3